It has been reported that selective MAO-A inhibitors, clorgyline and brofaromine, but not the MAO-B inhibitors, deprenyl and pargyline, stimulated rat pineal melatonin synthesis in humans and animals. Recent studies, however, found no effect of moclobemide, a selective MAO-A inhibitor, on human plasma melatonin levels. Present study found that in vitro moclobemide produced very weak stimulation of rat pineal NAT activity. However, in vivo moclobemide induced a significant increase of rat pineal NAS and melatonin content, and a dramatic decrease of 5-HIAA content (HPLC-fluorimetric procedure). Moclobemide's effect on melatonin and related indoles could be detected as early as 30 min after the injection and lasted, at least, for 2 h. The possible reasons for discrepancies between human and animal data are discussed.
CITATION STYLE
Oxenkrug, G. F., Requintina, P. J., & Yuwiler, A. (1990). Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do? Journal of Neural Transmission. Supplementum, 32, 171–175. https://doi.org/10.1007/978-3-7091-9113-2_25
Mendeley helps you to discover research relevant for your work.